CLS Holdings has exchanged unconditionally on the sale of its Fangdieckstrasse life sciences campus in Hamburg for €25.35 million, 9% below the latest valuation. The office landlord said the proceeds will be used to pay down debt, continuing a disposal programme aimed at bringing borrowing back towards its target range.

What CLS Holdings announced

In a regulatory announcement at 07:00 on 29 September 2026, CLS Holdings (LSE:CLI) said it had unconditionally exchanged on the sale of Fangdieckstrasse 75, 75a and 75b in Hamburg for €25.35 million. The company stated that the price is 9% below the latest valuation. On that basis, the latest valuation would be roughly €27.9 million, although CLS did not state the figure or the valuation date.

The property comprises approximately 13,116 sq m (141,180 sq ft) of office, laboratory and Training space. CLS said the asset is almost fully let, with a weighted average remaining Lease term of just under seven years. Completion is expected in the fourth quarter of 2026. The buyer was not named.

Background to the Hamburg sale

CLS bought the property in 2007. Since then, according to the company, it has repositioned the site by expanding laboratory and office capabilities and signing long-term leases, turning it into what it describes as "a life sciences campus".

Chief executive Fredrik Widlund said: "Following the successful repositioning of Fangdieckstrasse, we consider this the right time to dispose of the asset, further focusing our German portfolio and reducing debt."

The London-listed group owns and manages office space across the UK, Germany and France, so the sale trims its German exposure while retaining its presence in that market.

Why Debt reduction matters for CLS

The sale fits a wider strategy set out in the company's half-year results on 12 August 2026. At that point CLS reported a loan-to-value ratio of 51.6% at 30 June 2026, up from 50.0% at the end of 2025 and above its target range of 35% to 45%. Net debt was £808.3 million, down £44.2 million from the year end.

In the first half CLS completed £56.8 million of disposals, including The Brix in Germany, and had exchanged on a further £18.9 million for the Clockwork Building in London. It said it expected disposals of approximately £100 million for the full year, with a further £22.5 million under offer. The portfolio was valued at £1.6 billion, having fallen 4.6% in local currency during the half, and EPRA net tangible assets per share dropped 11.5% to 177.7p.

Risks for LSE stocks in the office sector

Selling below valuation crystallises a discount, and CLS did not say how the sale would affect net asset value. Using the proceeds to repay debt also removes rental income from a property the company described as almost fully let, which may weigh on earnings. Completion is not expected until the fourth quarter, so timing risk remains. More broadly, the half-year figures showed office valuations still falling across the UK, Germany and France, which can make it harder to cut Leverage through disposals alone.

What investors may watch next

For those following UK shares in the property sector, the next markers are completion of the Hamburg sale and further progress on the disposal target of approximately £100 million for 2026. Investors may also look for updates on loan-to-value and refinancing. CLS paid no Interim Dividend and said its board would consider a single final dividend based on full-year earnings, making the full-year results a further point of interest.

CLS Holdings' direction on the UK stock market

The Fangdieckstrasse deal shows CLS Holdings (LSE:CLI) selling a repositioned, well-let asset to shore up its balance sheet, even at a price below its latest valuation. Whether that trade-off pays off will depend on how quickly the group can bring its leverage back within its stated range.